Header cover image

Australian (ASX) Biotech Industry Analysis

UpdatedFeb 21, 2025
DataAggregated Company Financials
Companies32
  • 7D1.4%
  • 3M-3.8%
  • 1Y-3.0%
  • YTD-7.0%

Over the last 7 days, the Biotech industry has risen 2.2%, driven by gains from CSL of 1.9%. The industry has been flat over the past 12 months despite the gain this week. As for the next few years, earnings are expected to grow by 15% per annum.

Industry Valuation and Performance

Has the Australian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 21 Feb 2025AU$141.5bAU$24.8bAU$3.8b23x37.5x5.7x
Sun, 19 Jan 2025AU$148.9bAU$24.8bAU$3.7b24.3x40.1x6x
Tue, 17 Dec 2024AU$148.0bAU$24.2bAU$3.6b24.6x41x6.1x
Thu, 14 Nov 2024AU$151.4bAU$23.6bAU$3.5b26.7x43.2x6.4x
Sat, 12 Oct 2024AU$155.8bAU$22.9bAU$3.4b28.1x46x6.8x
Mon, 09 Sep 2024AU$157.8bAU$23.1bAU$3.4b28.9x46.1x6.8x
Wed, 07 Aug 2024AU$156.4bAU$22.7bAU$3.3b30.6x46.7x6.9x
Fri, 05 Jul 2024AU$154.7bAU$21.9bAU$3.2b32.2x48.2x7.1x
Sun, 02 Jun 2024AU$146.4bAU$22.1bAU$3.2b31.4x45.4x6.6x
Tue, 30 Apr 2024AU$142.8bAU$22.4bAU$3.3b30.4x43.6x6.4x
Thu, 28 Mar 2024AU$146.6bAU$22.5bAU$3.3b30x44.4x6.5x
Sat, 24 Feb 2024AU$144.9bAU$22.4bAU$3.3b36.6x43.7x6.5x
Mon, 22 Jan 2024AU$147.1bAU$20.8bAU$2.8b33.8x53.3x7.1x
Wed, 20 Dec 2023AU$142.8bAU$20.4bAU$2.7b34x53x7x
Fri, 17 Nov 2023AU$132.6bAU$21.1bAU$2.8b32.5x47.2x6.3x
Sun, 15 Oct 2023AU$123.8bAU$21.8bAU$2.9b29.8x43.2x5.7x
Tue, 12 Sep 2023AU$137.5bAU$21.4bAU$2.8b32.6x49.1x6.4x
Thu, 10 Aug 2023AU$134.6bAU$18.4bAU$2.4b36.4x56.4x7.3x
Sat, 08 Jul 2023AU$137.4bAU$18.0bAU$2.3b36.7x59.2x7.6x
Mon, 05 Jun 2023AU$157.2bAU$18.2bAU$2.4b40.2x66.7x8.6x
Wed, 03 May 2023AU$154.9bAU$18.1bAU$2.3b42.5x66.1x8.5x
Fri, 31 Mar 2023AU$145.5bAU$17.9bAU$2.3b39.6x62.9x8.1x
Sun, 26 Feb 2023AU$152.5bAU$17.7bAU$2.3b44.9x66.4x8.6x
Tue, 24 Jan 2023AU$152.4bAU$15.4bAU$2.4b53.9x62.6x9.9x
Thu, 22 Dec 2022AU$146.7bAU$16.1bAU$2.6b45.8x57x9.1x
Sat, 19 Nov 2022AU$150.5bAU$16.2bAU$2.6b43.4x58.5x9.3x
Mon, 17 Oct 2022AU$142.9bAU$17.2bAU$2.8b40.5x51.4x8.3x
Wed, 14 Sep 2022AU$151.0bAU$15.7bAU$2.5b47.8x60.4x9.6x
Fri, 12 Aug 2022AU$151.0bAU$15.2bAU$2.7b42.6x55.3x9.9x
Sun, 10 Jul 2022AU$145.5bAU$15.7bAU$2.8b38x51.3x9.3x
Tue, 07 Jun 2022AU$136.9bAU$15.0bAU$2.7b36.6x50.9x9.2x
Thu, 05 May 2022AU$138.7bAU$15.1bAU$2.8b36.4x50.2x9.2x
Sat, 02 Apr 2022AU$135.7bAU$14.3bAU$2.6b39.1x52.3x9.5x
Mon, 28 Feb 2022AU$134.1bAU$14.9bAU$2.6b38.7x50.9x9x
Price to Earnings Ratio

50.9x


Total Market Cap: AU$134.1bTotal Earnings: AU$2.6bTotal Revenue: AU$14.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Australian Biotech Industry Price to Earnings3Y Average 51.6x202320242025
Current Industry PE
  • Investors are pessimistic on the Australian Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 37.5x which is lower than its 3-year average PE of 51.6x.
  • The 3-year average PS ratio of 7.7x is higher than the industry's current PS ratio of 5.7x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have grown 13% per year over the last three years.
  • Revenues for these companies have grown 19% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Australian Healthcare industry?

AU Market-2.48%
Healthcare0.61%
Biotech1.38%
Biotech1.38%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CSL CSLAU$258.891.9%
+AU$2.4b
-9.2%PE29.1x
PAR Paradigm BiopharmaceuticalsAU$0.5610.9%
+AU$21.4m
51.4%PB9.2x
BDX BCAL DiagnosticsAU$0.1325.0%
+AU$9.1m
38.9%PS14.8x
ARX Aroa BiosurgeryAU$0.583.6%
+AU$6.9m
0.9%PS2.9x
ATH Alterity TherapeuticsAU$0.01110.0%
+AU$5.5m
120.0%PS15x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

TLX

AU$26.46

Telix Pharmaceuticals

7D

-2.4%

1Y

141.2%

CUV

AU$11.32

Clinuvel Pharmaceuticals

7D

0.6%

1Y

-20.9%

PYC

AU$1.28

PYC Therapeutics

7D

-2.3%

1Y

64.1%

MSB

AU$2.75

Mesoblast

7D

-5.2%

1Y

848.3%

CSL

AU$258.89

CSL

7D

1.9%

1Y

-9.2%

ACW

AU$0.037

Actinogen Medical

7D

-5.1%

1Y

-2.6%

ATH

AU$0.011

Alterity Therapeutics

7D

10.0%

1Y

120.0%

OPT

AU$0.97

Opthea

7D

-4.4%

1Y

54.8%

ATX

AU$0.082

Amplia Therapeutics

7D

3.8%

1Y

5.1%

IMM

AU$0.32

Immutep

7D

-1.6%

1Y

-10.0%

BDX

AU$0.13

BCAL Diagnostics

7D

25.0%

1Y

38.9%

DXB

AU$0.47

Dimerix

7D

-5.9%

1Y

131.7%

PAR

AU$0.56

Paradigm Biopharmaceuticals

7D

10.9%

1Y

51.4%

OCC

AU$1.46

Orthocell

7D

-6.7%

1Y

239.5%

PAB

AU$0.0025

Patrys

7D

25.0%

1Y

-75.0%